Bafna Pharmaceuticals Limited
Bafna Pharmaceuticals Limited is an Indian listed company in the Pharmaceuticals & Biotechnology industry (Healthcare sector), traded under NSE: BAFNAPH and BSE: 532989 (ISIN INE878I01022).
It has a market capitalisation of ₹1,113 crore, a last close of ₹470.55 on 2026-10-19, a one-year return of 227.0%.
Valuation: a price-to-earnings ratio of 143x, a price-to-book ratio of 11.58x, a dividend yield of 0.0%.
Profitability: return on equity of 12.3%, return on capital employed of 13.3%, an operating margin of 8.2%.
Growth: sales growth of 9.3% a year over three years, net profit growth of -0.7% a year over three years.
Balance sheet and ownership: debt-to-equity of 0.39x, promoter holding of 75.0%.
| Metric | Value |
|---|---|
| Market capitalisation | 1,113 |
| Last close | ₹470.55 |
| P/E (TTM) | 143x |
| P/B | 11.58x |
| Dividend yield | 0.0% |
| ROE (FY) | 12.3% |
| ROCE (FY) | 13.3% |
| Operating margin (TTM) | 8.2% |
| Sales growth, 3-year CAGR | 9.3% |
| Profit growth, 3-year CAGR | -0.7% |
| Debt / equity | 0.39x |
| Promoter holding | 75.0% |
| 1-year return | 227.0% |
Loading the live page with the price chart, financial history, shareholding and recent filings. Data is end-of-day and rebuilt nightly; nothing here is investment advice. Financial statements · What each metric means